Free Trial

C4 Therapeutics (CCCC) News Today

C4 Therapeutics logo
$1.52 +0.04 (+2.70%)
Closing price 07/7/2025 04:00 PM Eastern
Extended Trading
$1.50 -0.02 (-1.38%)
As of 07/7/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CCCC Latest News

Stifel Nicolaus Reaffirms Their Buy Rating on C4 Therapeutics (CCCC)
C4 Therapeutics announces anticipated 2025 milestones
C4 Therapeutics price target raised to $50 from $39 at Brookline
Wells Fargo Upgrades C4 Therapeutics (CCCC)
C4 Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
C4 Therapeutics
C4 Therapeutics (CCCC) Gets a Hold from Morgan Stanley
Get C4 Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CCCC and its competitors with MarketBeat's FREE daily newsletter.

CCCC Media Mentions By Week

CCCC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CCCC
News Sentiment

0.00

0.57

Average
Medical
News Sentiment

CCCC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CCCC Articles
This Week

0

2

CCCC Articles
Average Week

Get C4 Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CCCC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CCCC) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners